ARK Investment Management - COLLPLANT BIOTECHNOLOGIES LT ownership

COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 18 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of COLLPLANT BIOTECHNOLOGIES LT
ValueSharesWeighting
Q2 2022$2,192,000
-14.6%
235,660
+3.1%
0.01%
+18.2%
Q1 2022$2,566,000
-5.2%
228,657
+38.2%
0.01%
+37.5%
Q4 2021$2,707,000
-16.3%
165,454
-13.5%
0.01%0.0%
Q3 2021$3,233,000191,2900.01%
Other shareholders
COLLPLANT BIOTECHNOLOGIES LT shareholders Q3 2023
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 605,437$4,928,0009.60%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 693,066$5,544,0000.57%
VILLERE ST DENIS J & CO LLC 266,897$2,135,0000.16%
FNY Investment Advisers, LLC 5,000$40,0000.03%
BENJAMIN F. EDWARDS & COMPANY, INC. 71,810$585,0000.03%
SIMON QUICK ADVISORS, LLC 15,676$139,0000.02%
ARK Investment Management 235,660$2,192,0000.01%
Cohanzick Management, LLC 2,000$16,0000.01%
Zurcher Kantonalbank (Zurich Cantonalbank) 23,210$189,0000.00%
BROWN ADVISORY INC 77,349$619,0000.00%
View complete list of COLLPLANT BIOTECHNOLOGIES LT shareholders